Literature DB >> 11448409

Incidence and mechanism of presyncope and/or syncope associated with paroxysmal junctional tachycardia.

B Brembilla-Perrot1, D Beurrier, P Houriez, O Claudon, J Wertheimer.   

Abstract

The objectives of this study were to: (1) define the incidence of presyncope and/or syncope in patients with paroxysmal junctional tachycardias, (2) determine their causes, and (3) determine the outcome of symptoms. Syncope is a frequent problem and is often caused by paroxysmal tachycardia. The mechanism of hemodynamic instability is unknown. The population study consisted of 281 patients, consecutively recruited because they had paroxysmal tachycardia and a sinus rhythm on a normal electrocardiogram. Fifty-two patients (group I) had presyncope and/or syncope associated with tachycardia. The remaining patients (group II) had no loss of consciousness. Transesophageal programmed atrial stimulation used 1 and 2 atrial extrastimuli, delivered in a control state, and if necessary, after infusion of 20 to 30 microg of isoproterenol. Arterial blood pressure was monitored. Vagal maneuvers and echocardiogram were performed in all patients. Paroxysmal tachycardia was induced in 51 group I patients and 227 group II patients. Comparisons of groups I and II revealed that age (50 +/- 21 vs 49 +/- 17 years), presence of heart disease (10% vs 10%), mechanism of tachycardia with a predominance of atrioventricular nodal reentrant tachycardia (70.5% vs 76%), and rate of tachycardia (196 +/- 42 vs 189 +/- 37 beats/min) did not differ between the groups. However, there were differences in both groups with regard to significantly higher incidences of positive vasovagal maneuvers (35% vs 4%, p <0.01), isoproterenol infusion required to induce tachycardia (55% vs 17%, p <0.001), and vasovagal reaction at the end of tachycardia (41% vs 4%, p <0.05). Thirty-seven group I patients underwent radiofrequency ablation of the reentrant circuit, which suppressed presyncope and/or syncope in 36 of the 37 patients. Thus, presyncope and/or syncope frequently complicated the history of patients with paroxysmal junctional tachycardia (18.5%). Several mechanisms are implicated, but vasovagal reaction was the most frequent cause. Treatment of the tachycardia typically suppressed presyncope and/or syncope.

Entities:  

Mesh:

Year:  2001        PMID: 11448409     DOI: 10.1016/s0002-9149(01)01607-1

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Does syncope require rhythmic and non-rhythmic evaluation in patients with previous MI?

Authors:  B Brembilla-Perrot; C Suty-Selton; F Alla; P Y Zinzius; H Blangy; B Azman; A Terrier de la Chaise; P Louis; L Groben; K Djaballah; O Selton; S Magalhaes; L Muresan; J Cedano; A Abdelaal; N Sadoul
Journal:  Heart Asia       Date:  2010-07-29

2.  New insights into the clinical signs of supraventricular tachycardia: The "sign of lace-tying".

Authors:  Dominique Blommaert; Fabien Dormal; Olivier Deceuninck; Olivier Xhaet; Elisabeth Ballant; Luc De Roy
Journal:  Ann Noninvasive Electrocardiol       Date:  2017-06-08       Impact factor: 1.468

3.  Impact of transesophageal electrophysiologic study to elucidate the mechanism of arrhythmia on children with supraventricular tachycardia and no preexcitation.

Authors:  Béatrice Brembilla-Perrot; A Moulin-Zinsch; J M Sellal; J Schwartz; A Olivier; P Y Zinzius; C De Chillou; D Beurrier; M Rodermann; G Goudote; H Al Amoura; A Terrier de la Chaise; J Lemoine; J Rizk; J P Lethor; J L Anne Tisserand; S Taïhi; F Marçon
Journal:  Pediatr Cardiol       Date:  2013-04-23       Impact factor: 1.655

4.  Factors of negativity of electrophysiological study in children and teenagers complaining of tachycardia and prognostic significance.

Authors:  Béatrice Brembilla-Perrot; Alice Brembilla; Anne Moulin-Zinsch; Jean Marc Sellal; Arnaud Olivier; Vladimir Manenti; Thibaut Villemin; Jean Paul Lethor; Samira Taihï; Joseph Rizk; Marc Rodermann; François Marçon; Nicolas Girerd
Journal:  Pediatr Cardiol       Date:  2014-07-29       Impact factor: 1.655

5.  Development and validation of a new Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) with focus on symptom burden.

Authors:  Ulla Walfridsson; Kristofer Arestedt; Anna Stromberg
Journal:  Health Qual Life Outcomes       Date:  2012-04-30       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.